Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rho guanine nucleotide exchange factor 6 (ARHGEF6)
- Target
- ARHGEF6
- Molecular classification
- Enzyme (Guanine nucleotide exchange factor [GEF]), Signal transduction scaffold protein, Rho GEF protein family
01
Overview
Rho guanine nucleotide exchange factor 6 (ARHGEF6) is a multidomain protein acting both as a guanine nucleotide exchange factor (GEF) specifically for the Rho family GTPases Rac1 and Cdc42, and as a scaffolding protein for cellular signaling complexes[1][2][3][4]. It possesses DH/PH domains responsible for its GEF activity and SH3, coiled-coil, and calponin homology domains for scaffolding and protein-protein interactions[1][2][3]. ARHGEF6 regulates actin cytoskeleton remodeling, cell adhesion, and motility, and is essential for normal cognitive development and hair cell stereocilia maintenance in the cochlea; mutations are linked to X-linked intellectual disability and sensorineural hearing loss[2][4]. It forms complexes with partners like p21-activated kinases (PAK1, PAK2, and PAK3) and GIT proteins, orchestrating local cellular signaling[1][3]. Though no pharmacological drugs directly target ARHGEF6, its pathway is considered important in neurodevelopmental and cytoskeletal disorders.
- Other names
- ARHGEF6Alpha-Pix (or alpha-PIX, αPIX)COOL2 (or Cool-2)PIXAMRX46Rac/Cdc42 guanine nucleotide exchange factor 6
02
Mechanism of action
Guanine nucleotide exchange (facilitates the exchange of GDP for GTP on Rac1 and Cdc42, switching them to their active forms[1][2][3][4].)
03
Biological functions
Signal transduction (activator of small Rho family GTPases Rac1 and Cdc42[1][2][3][4])Regulation of actin cytoskeletonCell spreading and motilityScaffolding for kinase and cytoskeletal regulatorsCellular localization and organization of protein complexes
04
Disease associations
Intellectual disability (X-linked; mutations cause XLID46[2][4])Sensorineural hearing loss (mutations affect hair cell stereocilia maintenance[2])Potential roles in cancer, as with other Rho GTPase regulators (limited direct evidence for ARHGEF6)
05
Safety considerations
Potential neurodevelopmental effects if modulated (given its essential role in cognitive and auditory function[2][4].)Unknown off-target effects: Manipulation of ARHGEF6 could affect multiple pathways due to its central role in actin dynamics and scaffolding.
06
Biomarkers
ARHGEF6 mutation screening (for intellectual disability and certain sensorineural hearing loss phenotypes[2][4])Levels/activation states of Rac1 and Cdc42 (as downstream functional markers[2].)
Beyond the preview
Go deeper on Rho guanine nucleotide exchange factor 6 (ARHGEF6).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rho guanine nucleotide exchange factor 6 (ARHGEF6).